Targeted treatment trials for tuberous sclerosis and autism: no longer a dream-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted treatment trials for tuberous sclerosis and autism: no longer a dream

Published:2012-10 Issue:5 Volume:22 Page:895-901
ISSN:0959-4388
Container-title:Current Opinion in Neurobiology
language:en
Short-container-title:Current Opinion in Neurobiology

Author:

Sahin Mustafa

Funder

Novartis

Autism Speaks

Tuberous Sclerosis Alliance

NIH

John Merck Fund

Nancy Lurie Marks Family Foundation

Children's Hospital Boston Translational Research Program

Manton Family Foundation

Publisher

Elsevier BV

Subject

General Neuroscience

Reference59 articles.

1. The costs of autism;Ganz,2006

2. Autistic disturbances of affective contact;Kanner;Nervous Child,1943

3. Postnatal neurodevelopmental disorders: meeting at the synapse?;Zoghbi;Science,2003

4. Neuroanatomic observations of the brain in autism: a review and future directions;Bauman;Int J Dev Neurosci,2005

5. Autism at the beginning: microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism;Courchesne;Dev Psychopathol,2005

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast Cells in Autism Spectrum Disorder—The Enigma to Be Solved?;International Journal of Molecular Sciences;2024-02-24

2. From Mouse to Man: N-Methyl-d-Aspartic Acid Receptor Activation as a Promising Pharmacotherapeutic Strategy for Autism Spectrum Disorders;Medical Clinics of North America;2023-01

3. The importance of refined assessment of communication and social functioning in people with intellectual disabilities: Insights from neurogenetic syndrome research;Social and Communicative Functioning in Populations with Intellectual Disability: Rethinking Measurement;2023

4. A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder;Experimental Brain Research;2022-09-05

5. Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?;Molecular Psychiatry;2022-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3